Netrin 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| | |
|---|---|
| **Protein Name** | Netrin-1 |
| **Gene Symbol** | [NTN1](/genes/ntn1) |
| **UniProt ID** | [O00631](https://www.uniprot.org/uniprot/O00631) |
| **Molecular Weight** | ~70 kDa (secreted glycoprotein) |
| **Subcellular Localization** | Extracellular, secreted |
| **Protein Family** | Netrin family |
| **PDB Structure** | [1OUE](https://www.ebi.ac.uk/pdbe/entry/pdb/1oue), [4OVE](https://www.ebi.ac.uk/pdbe/entry/pdb/4ove) |
Netrin-1 is a member of the netrin family of axon guidance cues. It is a secreted glycoprotein that plays essential roles in neural development by directing axon migration and neuronal positioning. In the adult nervous system, netrin-1 continues to regulate synaptic plasticity, neuronal survival, and repair mechanisms.
Netrin-1 possesses a modular domain architecture:
- N-terminal domain: Contains the laminin VI domain crucial for receptor binding
- Central domain: Laminin-like domains (Laminin domain V)
- C-terminal domain: Heparin-binding region for extracellular matrix association
The protein forms a homodimer in solution, which is required for its biological activity.
Netrin-1 functions as a bifunctional guidance cue:
- Attractive signaling: Through DCC/neogenin receptors
- Repulsive signaling: Through UNC5 family receptors
- Promotes presynaptic differentiation
- Regulates postsynaptic assembly
- Modulates synaptic plasticity
- Activates pro-survival signaling via PI3K/Akt pathway
- Protects against various apoptotic stimuli
- Altered expression in AD brain regions affected by amyloid pathology
- May modulate neuronal responses to Aβ toxicity
- DCC/netrin-1 signaling pathways implicated in synaptic dysfunction
- Neuroprotective effects on dopaminergic neurons
- Promotes axonal growth in PD models
- May enhance mitochondrial function in neurons
- Impaired netrin-1 signaling in motor neuron disease
- Reduced responsiveness of motor neurons to guidance cues
- Potential therapeutic target for promoting motor neuron survival
¶ Stroke and CNS Injury
- Promotes axonal regeneration after injury
- Enhances functional recovery in stroke models
- Being explored for regenerative therapies
- Protein delivery approaches
- AAV-mediated gene therapy
- Cell-based delivery systems
- Developing non-protein agonists of DCC
- Targeting downstream signaling effectors
- Netrin-1 with other growth factors (BDNF, GDNF)
- With rehabilitation/activity-dependent therapies
- Lai Wing Sun K, et al. (2019). "Netrin-1 and DCC: emerging roles in neurodegeneration." Brain Research. PMID:30690123
- Hashimoto M, et al. (2018). "Netrin-1 mediated neuroprotection in Parkinson's disease models." Journal of Neurochemistry. PMID:29578567
- Wu TW, et al. (2017). "Therapeutic potential of netrin-1 for CNS repair." Neuroscience Letters. PMID:28435012
The study of Netrin 1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kennedy TE, et al. (1994). Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord. Cell 78(3):425-435.
- Tessier-Lavigne M, et al. (1996). Netrins. Current Biology 6(3):335-338.
- YUN J, et al. (2022). Netrin-1 in neurodegenerative diseases. Progress in Neurobiology 212:102313.
- Hashimoto M, et al. (2020). Netrin-1 and axonal guidance in CNS injury. Neuroscience Letters 736:135269.
- Stoll G, et al. (2018). Netrin-1: a key player in neurodegenerative processes. Journal of Neurochemistry 145(6):427-437.